pravastatin has been researched along with Calcinosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltrusaitis, K; Braddock, DT; Cleveland, RH; D'Agostino, RB; Gordon, CM; Gordon, LB; Kieran, MW; Kleinman, ME; Li, X; Liang, MG; Massaro, J; Snyder, B; Walters, M | 1 |
Akishita, M; Iijima, K; Ito, Y; Ouchi, Y; Son, BK | 1 |
Anseth, KS; Benton, JA; Kern, HB; Leinwand, LA; Mariner, PD | 1 |
Cheng, G; Elmariah, S; Kaplan, FS; Mohler, ER; Wu, B | 1 |
Akishita, M; Eto, M; Iijima, K; Kozaki, K; Nakano, T; Ouchi, Y; Son, BK | 1 |
Griffin, BP; Lauer, MS; Novaro, GM; Pearce, GL; Sprecher, DL; Tiong, IY | 1 |
6 other study(ies) available for pravastatin and Calcinosis
Article | Year |
---|---|
Extraskeletal Calcifications in Hutchinson-Gilford Progeria Syndrome.
Topics: Calcinosis; Calcium; Child; Child, Preschool; Creatinine; Female; Fibroblast Growth Factor-23; Humans; In Vitro Techniques; Lamin Type A; Male; Parathyroid Hormone; Piperidines; Pravastatin; Progeria; Pyridines; Zoledronic Acid | 2019 |
Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Calcinosis; Drug Synergism; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Male; Pravastatin; Rats; Rats, Wistar; Renal Insufficiency; Tetrazoles | 2014 |
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression.
Topics: Actins; Animals; Aortic Valve; Calcinosis; Cell Proliferation; Cells, Cultured; Fibroblasts; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Contraction; Muscle, Smooth; Pravastatin; Probability; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Swine; Transfection | 2009 |
Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
Topics: Animals; Aortic Valve; Calcinosis; Cell Differentiation; Cells, Cultured; Cholesterol; Fibroblasts; Heart Valve Diseases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Osteoblasts; Pravastatin; Protein Prenylation; Simvastatin; Stromal Cells; Swine | 2005 |
Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells.
Topics: Androstadienes; Apoptosis; Axl Receptor Tyrosine Kinase; bcl-Associated Death Protein; Calcinosis; Caspase 3; Cells, Cultured; Enzyme Activation; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Intercellular Signaling Peptides and Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oncogene Proteins; Phosphates; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Pravastatin; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptor Protein-Tyrosine Kinases; Signal Transduction; Wortmannin | 2007 |
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.
Topics: Aged; Aortic Valve Stenosis; Atorvastatin; Calcinosis; Cholesterol, HDL; Cholesterol, LDL; Disease Progression; Echocardiography; Electrocardiography; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Multivariate Analysis; Pravastatin; Pyrroles; Retrospective Studies; Risk Factors; Simvastatin; Treatment Outcome; Triglycerides; Vascular Patency | 2001 |